Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial - Archive ouverte HAL
Journal Articles Lancet Oncology Year : 2014

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Julien Taieb
  • Function : Author
Josep Tabernero
  • Function : Author
Enrico Mini
  • Function : Author
Fabien Subtil
Laboratoire de Biométrie et Biologie Evolutive - UMR 5558
Service de Biostatistiques [Lyon]
Hospices Civils de Lyon
CV
Gunnar Folprecht
  • Function : Author
Jean-Luc van Laethem
  • Function : Author
Josef Thaler
  • Function : Author
John Bridgewater
  • Function : Author
Lone Nørgård Petersen
  • Function : Author
Hélène Blons
  • Function : Author
Laurence Collette
  • Function : Author
Eric van Cutsem
  • Function : Author
Philippe Rougier
  • Function : Author
Ramon Salazar
  • Function : Author
Laurent Bedenne
  • Function : Author
Jean-François Emile
  • Function : Author
Pierre Laurent-Puig
  • Function : Author
Come Lepage
  • Function : Author

Domains

Life Sciences [q-bio]

Fabien Subtil  : Connect in order to contact the contributor

https://hal.science/hal-04179712

Submitted on : Thursday, August 10, 2023-11:27:45 AM

Last modification on : Saturday, May 18, 2024-3:15:35 AM

Consult the full text

Dates and versions

hal-04179712 , version 1 (10-08-2023)

Identifiers

Cite

Julien Taieb, Josep Tabernero, Enrico Mini, Fabien Subtil, Gunnar Folprecht, et al.. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial. Lancet Oncology, 2014, 15 (8), pp.862-873. ⟨10.1016/S1470-2045(14)70227-X⟩. ⟨hal-04179712⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

HCL CNRS UNIV-LYON1 BIOENVIS LBBE UDL ANR
18 View
0 Download

Altmetric

Share

More